Back to search

Article

Molecular and Clinical Characteristics Associated with Elevated TREM1 and its Emergence as a Prognostic Biomarker in Gliomas

2021-10-12

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> Monotherapy with immune checkpoint blockade for most gliomas does not seem to induce durable antitumor responses, which drive us to explore potential immunological targets in glioma. Triggering receptor expressed on myeloid cells-1 (TREM1) has been reported to be associated with immune-related inflammatory disorders. However, to date, there has rarely been studi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
435c7700-e2b7-5ddd-acce-a5865cd91fe6
DOI
10.21203/rs.3.rs-958851/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Molecular and Clinical Characteristics Associated with Elevated TREM1 and its Emergence as a Prognostic Biomarker in GliomasDOI 10.21203/rs.3.rs-958851/v1
High expression of Triggering Receptor Expressed on Myeloid Cells 1 (TREM-1) predicted poor prognosis in Glioblastoma multiformeSemantic proximity
Prognostic and predictive value of FCER1G in glioma outcomes and response to immunotherapySemantic proximity
A Novel MALT1-related Immune Prognostic Signature and Targeted Drug Screening for GlioblastomaSemantic proximity
Immune-related matrisomes are potential biomarkers to predict the prognosis and immune microenvironment of glioma patients through bioinformatics analysis and experimental verificationSemantic proximity
MR1 overexpression correlates with poor clinical prognosis in glioma patientsSemantic proximity
Comprehensive analysis of m6A/m5C/m1A-related gene expression, immune infiltration, and sensitivity of antineoplastic drugs in gliomaSemantic proximity
Development of An Inflammatory Response-Related Gene Signature To Predict Prognosis and Immunotherapy Response For Patients With GliomaSemantic proximity
TREM2 promotes glioma progression and angiogenesis mediated by microglia/brain macrophagesSemantic proximity
Development of a prognostic model of glioma based on immune‑related genesSemantic proximity
Prognostic risk of immune-associated signature in the microenvironment of brain gliomasSemantic proximity
Comprehensive Molecular Analyses of a Novel Mutational Signature Classification System with Regard to Prognosis, Genomic Alterations, and Immune Landscape in GliomaSemantic proximity
Development of a tumor microenvironment-related prognostic signature in glioma to predict immune landscape and potential therapeutic drugs.Semantic proximity
Select a neighboring publication to make it the new centre.